Next Article in Journal
Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
Next Article in Special Issue
Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells
Previous Article in Journal
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
 
 
Article

Article Versions Notes

Cancers 2020, 12(5), 1123; https://doi.org/10.3390/cancers12051123
Action Date Notes Link
article xml file uploaded 30 April 2020 12:03 CEST Original file -
article pdf uploaded. 30 April 2020 12:03 CEST Version of Record https://www.mdpi.com/2072-6694/12/5/1123/pdf-vor
article supplementary file uploaded. 30 April 2020 12:03 CEST - https://www.mdpi.com/2072-6694/12/5/1123#supplementary
article xml file uploaded 30 April 2020 12:04 CEST Update -
article pdf uploaded. 30 April 2020 12:04 CEST Updated version of record https://www.mdpi.com/2072-6694/12/5/1123/pdf-vor
article xml file uploaded 19 May 2020 05:34 CEST Update -
article xml uploaded. 19 May 2020 05:34 CEST Update https://www.mdpi.com/2072-6694/12/5/1123/xml
article pdf uploaded. 19 May 2020 05:34 CEST Updated version of record https://www.mdpi.com/2072-6694/12/5/1123/pdf
article html file updated 19 May 2020 05:35 CEST Original file -
article html file updated 5 June 2020 16:45 CEST Update -
article html file updated 21 July 2022 03:30 CEST Update https://www.mdpi.com/2072-6694/12/5/1123/html
Back to TopTop